Diffusion Pharmaceuticals Stock Number Of Shares Shorted
DFFNDelisted Stock | USD 4.62 0.07 1.54% |
Diffusion Pharmaceuticals fundamentals help investors to digest information that contributes to Diffusion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Diffusion Stock. The fundamental analysis module provides a way to measure Diffusion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Diffusion Pharmaceuticals stock.
Diffusion |
Diffusion Pharmaceuticals Company Number Of Shares Shorted Analysis
Diffusion Pharmaceuticals' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Diffusion Pharmaceuticals Number Of Shares Shorted | 2.54 K |
Most of Diffusion Pharmaceuticals' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Diffusion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Diffusion Pharmaceuticals has 2.54 K of outstending shares currently sold short by investors. This is 99.92% lower than that of the Biotechnology sector and 99.95% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.95% higher than that of the company.
Diffusion Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Diffusion Pharmaceuticals' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Diffusion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Diffusion Pharmaceuticals by comparing valuation metrics of similar companies.Diffusion Pharmaceuticals is currently under evaluation in number of shares shorted category among related companies.
Diffusion Fundamentals
Return On Equity | -0.64 | |||
Return On Asset | -0.38 | |||
Current Valuation | (6.02 M) | |||
Shares Outstanding | 2.04 M | |||
Shares Owned By Insiders | 0.23 % | |||
Shares Owned By Institutions | 10.27 % | |||
Number Of Shares Shorted | 2.54 K | |||
Price To Earning | (0.60) X | |||
Price To Book | 0.51 X | |||
EBITDA | (15.97 M) | |||
Net Income | (15.59 M) | |||
Cash And Equivalents | 25.86 M | |||
Cash Per Share | 12.68 X | |||
Total Debt | 67.89 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 11.59 X | |||
Book Value Per Share | 6.97 X | |||
Cash Flow From Operations | (14.97 M) | |||
Short Ratio | 0.29 X | |||
Earnings Per Share | (7.11) X | |||
Target Price | 40.0 | |||
Number Of Employees | 13 | |||
Beta | 1.76 | |||
Market Capitalization | 8.98 M | |||
Total Asset | 22.64 M | |||
Retained Earnings | (145.6 M) | |||
Working Capital | 20.22 M | |||
Current Asset | 3.29 M | |||
Current Liabilities | 3.68 M | |||
Z Score | 69.08 | |||
Net Asset | 22.64 M |
About Diffusion Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diffusion Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diffusion Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diffusion Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Diffusion Pharmaceuticals information on this page should be used as a complementary analysis to other Diffusion Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Diffusion Stock
If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |